| 摘要 |
FIELD: medicine, hepatology, pharmacy. SUBSTANCE: invention proposes novel component of pharmaceutical composition, food composition or beverage used for prophylaxis or treatment of hepatic lipid dystrophy or hepatic cirrhosis in mammals, among them, humans. As such component the known flavonoids naringin or naringenin are used. EFFECT: expanded assortment of agents of designation claimed. 9 cl, 6 dwg, 6 tbl, 10 ex |
